Nanologica to attend Pittcon Mar. 3-5 in Chicago

Nanologica will be attending the Pittcon conference in Chicago, Mar. 3-5, to meet with potential customers in the chromatography field, as the first step in deepening the presence on the American market.

Nanologica has so far conducted limited explorations of the American market. With the ongoing development of the Company’s products for chromatography, and the successful evaluation of beta versions of new columns, Nanologica now has the product portfolio necessary to meet the needs and expectations of the American market.

At Pittcon, Nanologica will be presenting the Company’s products and technology to interested customers as well as broadening the Company’s network. Customers wishing to meet with Nanologica will find the company at booth number 1748.

Pittcon is the world’s leading annual conference and exposition on laboratory science. The conference attracts attendees from industry, academia and government from over 90 countries worldwide. Pittcon’s target audience is anyone who develops, buys, or sells laboratory equipment, performs physical or chemical analyses, develops analysis methods, or manages scientists. Pittcon has evolved into a multifaceted event that serves a diverse constituency encompassing life sciences, industrial manufacturing, environmental, forensic, art preservation, and food sciences.

 

To schedule a meeting or receive further information, please contact:

Andreas Bhagwani, CEO Nanologica AB
phone: +46 70 316 17 02 or e-mail: andreas.bhagwani@nanologica.com

 About Nanologica AB (publ)
Nanologica was founded in 2004 and is a nanotechnology company developing nanoporous silica particles for applications within life science. Nanologica is world-leading in controlling the shape, size and type of porosity of silica particles. This knowledge is applied within drug development and chromatography (a separation technique used in drug development and drug production). The company’s mission is to contribute to better and cheaper treatments for patients worldwide through the technology platform NLAB Silica™. Nanologica’s stock (NICA) is listed on Spotlight Stock Market. For further information, please visit www.nanologica.com.

Share this:

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print